Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H9Cl3N2O |
Molecular Weight | 315.582 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C(NC(=O)NC2=CC=C(Cl)C(Cl)=C2)C=C1
InChI
InChIKey=ICUTUKXCWQYESQ-UHFFFAOYSA-N
InChI=1S/C13H9Cl3N2O/c14-8-1-3-9(4-2-8)17-13(19)18-10-5-6-11(15)12(16)7-10/h1-7H,(H2,17,18,19)
Molecular Formula | C13H9Cl3N2O |
Molecular Weight | 315.582 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionCurator's Comment: Description was created using several sources including:
http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm517478.htm; http://www.fda.gov/downloads/aboutfda/reportsmanualsforms/reports/economicanalyses/ucm519798.pdf; https://www.ncbi.nlm.nih.gov/pubmed/22626523; https://www.ncbi.nlm.nih.gov/pubmed/21131331; http://www.ncbi.nlm.nih.gov/pubmed/?term=12534815
Curator's Comment: Description was created using several sources including:
http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm517478.htm; http://www.fda.gov/downloads/aboutfda/reportsmanualsforms/reports/economicanalyses/ucm519798.pdf; https://www.ncbi.nlm.nih.gov/pubmed/22626523; https://www.ncbi.nlm.nih.gov/pubmed/21131331; http://www.ncbi.nlm.nih.gov/pubmed/?term=12534815
Triclocarban is a triclosan analogue with an antibmicrobial property. It has been used in a wide range of personal cleansing products including deodorant and bar soaps, deodorants, detergents, cleansing lotions, and wipes. In US triclocarban was approved for marketing of over-the-counter (OTC) consumer antiseptic wash products. But on September 2, 2016 U.S. Food and Drug Administration banned containing triclocarban and triclosan consumer antiseptic wash products from further marketing in USA because of a potential damage to human health, resulting from extended exposure to antiseptic active ingredients on a regular bases. However the new rule does not not affect consumer hand “sanitizers” or wipes, or antibacterial products used in health care settings. Triclocarban is a limited spectrum antibacterial agent effective in vitro against some strains of staphylococcus, streptococcus, and enterococcus bacteria. The minimum inhibitory concentration has been found to range from 0.5 to 8 mg/L for these various strains. Triclocarban can act by non-specific membrane-destabilizing mechanism; also was suggested, that similar to triclosan, Triclocarban exerts its effect by inhibiting the activity of enoyl-(acyl-carrier protein) (ACP) reductase, widely distributed in bacteria, fungi and plants. As a result, this agent interrupts cell membrane synthesis and leads to bacterial growth inhibition.
Approval Year
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
8.6 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1109279/ |
103 μg single, intravenous dose: 103 μg route of administration: Intravenous experiment type: SINGLE co-administered: |
TRICLOCARBAN blood | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
Doses
Dose | Population | Adverse events |
---|---|---|
9 % 1 times / day multiple, topical Highest studied dose Dose: 9 %, 1 times / day Route: topical Route: multiple Dose: 9 %, 1 times / day Sources: |
healthy, 21 to 65 years old n = 10 Health Status: healthy Age Group: 21 to 65 years old Sex: M Population Size: 10 Sources: |
Other AEs: Skin irritation... Other AEs: Skin irritation (grade 1) Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Skin irritation | grade 1 | 9 % 1 times / day multiple, topical Highest studied dose Dose: 9 %, 1 times / day Route: topical Route: multiple Dose: 9 %, 1 times / day Sources: |
healthy, 21 to 65 years old n = 10 Health Status: healthy Age Group: 21 to 65 years old Sex: M Population Size: 10 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Simultaneous determination of 21 preservatives in cosmetics by ultra performance liquid chromatography. | 2008 Oct |
|
In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens. | 2008 Sep |
|
Meta-analysis of mass balances examining chemical fate during wastewater treatment. | 2008 Sep 1 |
|
Determination of triclosan, triclocarban and methyl-triclosan in aqueous samples by dispersive liquid-liquid microextraction combined with rapid liquid chromatography. | 2009 Apr 10 |
|
Runoff of pharmaceuticals and personal care products following application of dewatered municipal biosolids to an agricultural field. | 2009 Aug 1 |
|
Toxicology in the fast lane: application of high-throughput bioassays to detect modulation of key enzymes and receptors. | 2009 Dec |
|
Fate of organohalogens in US wastewater treatment plants and estimated chemical releases to soils nationwide from biosolids recycling. | 2009 Dec |
|
Bioaccumulation of triclocarban in Lumbriculus variegatus. | 2009 Dec |
|
Pharmaceutical and personal care products in tile drainage following surface spreading and injection of dewatered municipal biosolids to an agricultural field. | 2009 Jul 1 |
|
Simultaneous determination of parabens, triclosan and triclocarban in water by liquid chromatography/electrospray ionisation tandem mass spectrometry. | 2009 Jun |
|
Adsorption and degradation of triclosan and triclocarban in soils and biosolids-amended soils. | 2009 Jun 10 |
|
Detection of the antimicrobials triclocarban and triclosan in agricultural soils following land application of municipal biosolids. | 2009 May |
|
Comparative microscale analysis of the effects of triclosan and triclocarban on the structure and function of river biofilm communities. | 2009 May 1 |
|
Effect of triclosan and triclocarban biocides on biodegradation of estrogens in soils. | 2009 Nov |
|
Impact of biosolids on the persistence and dissipation pathways of triclosan and triclocarban in an agricultural soil. | 2009 Nov 15 |
|
On-line solid-phase extraction of large-volume injections coupled to liquid chromatography-tandem mass spectrometry for the quantitation and confirmation of 14 selected trace organic contaminants in drinking and surface water. | 2009 Nov 27 |
|
Ultra-high-performance liquid chromatography-tandem mass spectrometry for determining the presence of eleven personal care products in surface and wastewaters. | 2009 Oct 16 |
|
Fate of triclocarban during soil aquifer treatment: soil column studies. | 2010 |
|
The antimicrobial triclocarban stimulates embryo production in the freshwater mudsnail Potamopyrgus antipodarum. | 2010 Apr |
|
Stir-bar-sorptive extraction and ultra-high-performance liquid chromatography-tandem mass spectrometry for simultaneous analysis of UV filters and antimicrobial agents in water samples. | 2010 Aug |
|
Uptake of pharmaceutical and personal care products by soybean plants from soils applied with biosolids and irrigated with contaminated water. | 2010 Aug 15 |
|
Electrochemistry-mass spectrometry unveils the formation of reactive triclocarban metabolites. | 2010 Dec |
|
Occurrence and loss over three years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms. | 2010 Dec |
|
Mass loadings of triclosan and triclocarbon from four wastewater treatment plants to three rivers and landfill in Savannah, Georgia, USA. | 2010 Feb |
|
Pharmaceuticals and personal care products in archived U.S. biosolids from the 2001 EPA National Sewage Sludge Survey. | 2010 Jan |
|
Occurrence and risks of triclosan and triclocarban in the Pearl River system, South China: from source to the receiving environment. | 2010 Jul 15 |
|
Self-reported chemicals exposure, beliefs about disease causation, and risk of breast cancer in the Cape Cod Breast Cancer and Environment Study: a case-control study. | 2010 Jul 20 |
|
Analysis of triclosan and triclocarban in soil and biosolids using molecularly imprinted solid phase extraction coupled with HPLC-UV. | 2010 Jul-Aug |
|
Transformation of triclosan and triclocarban in soils and biosolids-applied soils. | 2010 Jul-Aug |
|
Characterization of the androgen-sensitive MDA-kb2 cell line for assessing complex environmental mixtures. | 2010 Jun |
|
Temperature-controlled ionic liquid dispersive liquid-phase microextraction for the sensitive determination of triclosan and triclocarban in environmental water samples prior to HPLC-ESI-MS/MS. | 2010 Jun |
|
Quantitative gene monitoring of microbial tetracycline resistance using magnetic luminescent nanoparticles. | 2010 Jun |
|
Trace determination of triclosan and triclocarban in environmental water samples with ionic liquid dispersive liquid-phase microextraction prior to HPLC-ESI-MS-MS. | 2010 Jun |
|
Measured physicochemical characteristics and biosolids-borne concentrations of the antimicrobial Triclocarban (TCC). | 2010 Jun 1 |
|
Fate of 14C-triclocarban in biosolids-amended soils. | 2010 Jun 1 |
|
Triclocarban, triclosan, polybrominated diphenyl ethers, and 4-nonylphenol in biosolids and in soil receiving 33-year biosolids application. | 2010 Mar |
|
Quantitative determination of triclocarban in wastewater effluent by stir bar sorptive extraction and liquid desorption-liquid chromatography-tandem mass spectrometry. | 2010 Mar 12 |
|
Some flame retardants and the antimicrobials triclosan and triclocarban enhance the androgenic activity in vitro. | 2010 Nov |
|
Personal care products and endocrine disruption: A critical review of the literature. | 2010 Nov |
|
Identification of wastewater bacteria involved in the degradation of triclocarban and its non-chlorinated congener. | 2010 Nov 15 |
|
Aquatic hazard assessment for pharmaceuticals, personal care products, and endocrine-disrupting compounds from biosolids-amended land. | 2010 Oct |
|
Rapid resolution liquid chromatography-tandem mass spectrometry method for the determination of endocrine disrupting chemicals (EDCs), pharmaceuticals and personal care products (PPCPs) in wastewater irrigated soils. | 2010 Oct |
|
Retention-release characteristics of triclocarban and triclosan in biosolids, soils, and biosolids-amended soils. | 2010 Sep |
|
Triclocarban and triclosan biodegradation at field concentrations and the resulting leaching potentials in three agricultural soils. | 2010 Sep |
|
Use of chemical mixtures to differentiate mechanisms of endocrine action in a small fish model. | 2010 Sep 1 |
|
Computational thermochemistry of six ureas, imidazolidin-2-one, N,N'-trimethyleneurea, benzimidazolinone, parabanic acid, barbital (5,5'-diethylbarbituric acid), and 3,4,4'-trichlorocarbanilide, with an extension to related compounds. | 2010 Sep 2 |
|
Effects of bisphenol A and triclocarban on brain-specific expression of aromatase in early zebrafish embryos. | 2011 Oct 25 |
|
Inhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine model. | 2011 Sep 1 |
|
Triclocarban mediates induction of xenobiotic metabolism through activation of the constitutive androstane receptor and the estrogen receptor alpha. | 2012 |
|
Effects of triclocarban on the transcription of estrogen, androgen and aryl hydrocarbon receptor responsive genes in human breast cancer cells. | 2013 Aug |
Patents
Sample Use Guides
Use Dial® soap containing 0.30% triclocarban for hand and body wash
Route of Administration:
Other
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/?term=12534815
To study effects of antimicrobial agents on the growth of P. aeruginosa at 37°C triclocarban at concentrations of 0 - 5 ug/ml were used
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:22:17 GMT 2023
by
admin
on
Fri Dec 15 15:22:17 GMT 2023
|
Record UNII |
BGG1Y1ED0Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
27901
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3630
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
m11089
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | Merck Index | ||
|
2017
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
C47770
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
202-924-1
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
38609
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | RxNorm | ||
|
BGG1Y1ED0Y
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
7547
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
TRICLOCARBAN
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
72005
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
5009
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
1681800
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
48347
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
C009540
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
BGG1Y1ED0Y
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
DB11155
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
100000077518
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
CHEMBL1076347
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
101-20-2
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
SUB11271MIG
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY | |||
|
DTXSID4026214
Created by
admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||